- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostate Carcinoma in New Zealand
Total 5169 results
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Lumicell, Inc.TerminatedProstate Cancer | Neoplasm, ResidualUnited States
-
Rutgers, The State University of New JerseyCompleted
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
Northwest BiotherapeuticsWithdrawnProstate CancerUnited States
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
Heinrich-Heine University, DuesseldorfUnknown
-
Lava TherapeuticsMerck Sharp & Dohme LLCRecruitingMetastatic Castration Resistant Prostate CancerUnited States, Spain, Netherlands
-
Peter MacCallum Cancer Centre, AustraliaUnited States Department of Defense; Advanced Accelerator Applications; Australian... and other collaboratorsActive, not recruitingMetastatic Hormone Naive Prostate CancerAustralia
-
Progen PharmaceuticalsAventis Pharmaceuticals; Northern Sydney and Central Coast Area Health ServiceCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingProstate CancerUnited States
-
AstraZenecaParexelCompleted
-
Concord Repatriation General HospitalRecruitingHCC | Hepatocellular CarcinomaAustralia, New Zealand
-
Costantine AlbanyHoosier Cancer Research Network; Achieve Life SciencesTerminatedProstate Cancer | PSA | Metastatic Castrate-Resistant Prostate CancerUnited States, Canada
-
Watson PharmaceuticalsCompletedProstate CancerUnited States
-
Ascenta TherapeuticsCompletedProstate CancerUnited States
-
Xencor, Inc.RecruitingMetastatic Castration-Resistant Prostate CancerUnited States
-
Weill Medical College of Cornell UniversityRecruitingProstate CancerUnited States
-
Weill Medical College of Cornell UniversityActive, not recruiting
-
Icahn School of Medicine at Mount SinaiActive, not recruiting
-
Icahn School of Medicine at Mount SinaiSanofi; BayerCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAragon Pharmaceuticals, Inc.Completed
-
Trans Tasman Radiation Oncology GroupCompletedNasopharyngeal Cancer | Anal Cancer | Intermediate Risk Prostate Cancer | Prostate Cancer (Post Prostatectomy)Australia
-
Duke UniversityJohns Hopkins University; Memorial Sloan Kettering Cancer Center; University... and other collaboratorsCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)SuspendedProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8Canada, United States
-
RhoVac APSActive, not recruitingProstate Cancer RecurrentSweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Novo Nordisk A/STerminated
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Candel Therapeutics, Inc.Active, not recruitingProstate CancerUnited States, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
AstraZenecaCompletedProstate CancerUnited Kingdom, Germany, United States
-
Weill Medical College of Cornell UniversityTerminatedQuality of Life | Prostate CancerUnited States
-
Apollomics (Australia) Pty. Ltd.Novotech (Australia) Pty Limited; Apollomics Inc. (formerly CBT Pharmaceuticals...TerminatedRenal Cell Carcinoma | Hepatocellular CarcinomaAustralia, New Zealand
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
Veru Inc.TerminatedMetastatic Castration-resistant Prostate Cancer | Androgen Resistant Prostatic CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States, Canada
-
American Medical SystemsCompleted
-
Cougar Biotechnology, Inc.CompletedProstatic Neoplasms | Prostate CancerUnited States, United Kingdom
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsUnited States, Canada
-
State University of New York at BuffaloRecruitingProstate CancerUnited States
-
Yale UniversityPfizerRecruiting
-
Weill Medical College of Cornell UniversityRecruiting
-
Hackensack Meridian HealthUppsala University, Sweden (Department of Immunology, Genetics and Pathology)Suspended
-
Weill Medical College of Cornell UniversityPOINT BiopharmaSuspendedProstate CancerUnited States
-
Martin GutierrezNovartisWithdrawnProstate CancerUnited States